These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

298 related articles for article (PubMed ID: 32739864)

  • 1. A surrogate of Roux-en-Y gastric bypass (the enterogastro anastomosis surgery) regulates multiple beta-cell pathways during resolution of diabetes in ob/ob mice.
    Amouyal C; Castel J; Guay C; Lacombe A; Denom J; Migrenne-Li S; Rouault C; Marquet F; Georgiadou E; Stylianides T; Luquet S; Le Stunff H; Scharfmann R; Clément K; Rutter GA; Taboureau O; Magnan C; Regazzi R; Andreelli F
    EBioMedicine; 2020 Aug; 58():102895. PubMed ID: 32739864
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Roux-en-Y gastric bypass restores islet function and morphology independent of body weight in ZDF rats.
    Mosinski JD; Aminian A; Axelrod CL; Batayyah E; Romero-Talamas H; Daigle C; Mulya A; Scelsi A; Schauer PR; Brethauer SA; Kirwan JP
    Am J Physiol Endocrinol Metab; 2021 Feb; 320(2):E392-E398. PubMed ID: 33427046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. GK-rats respond to gastric bypass surgery with improved glycemia despite unaffected insulin secretion and beta cell mass.
    Miskelly MG; Shcherbina L; Thorén Fischer AH; Abels M; Lindqvist A; Wierup N
    Peptides; 2021 Feb; 136():170445. PubMed ID: 33197511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sitagliptin and Roux-en-Y gastric bypass modulate insulin secretion via regulation of intra-islet PYY.
    Guida C; McCulloch LJ; Godazgar M; Stephen SD; Baker C; Basco D; Dong J; Chen D; Clark A; Ramracheya RD
    Diabetes Obes Metab; 2018 Mar; 20(3):571-581. PubMed ID: 28892258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass.
    Bojsen-Møller KN
    Dan Med J; 2015 Apr; 62(4):B5057. PubMed ID: 25872541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Diabetes Remission and Micronutrient Deficiency in a Mildly Obese Diabetic Rat Model Undergoing SADI-S Versus RYGB.
    Wang T; Shen Y; Qiao Z; Wang Y; Zhang P; Yu B
    Obes Surg; 2019 Apr; 29(4):1174-1184. PubMed ID: 30610678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased β-Cell Mass in Obese Rats after Gastric Bypass: A Potential Mechanism for Improving Glycemic Control.
    Zhang S; Guo W; Wu J; Gong L; Li Q; Xiao X; Zhang J; Wang Z
    Med Sci Monit; 2017 May; 23():2151-2158. PubMed ID: 28477035
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contribution of endogenous glucagon-like peptide-1 to changes in glucose metabolism and islet function in people with type 2 diabetes four weeks after Roux-en-Y gastric bypass (RYGB).
    Shah M; Laurenti MC; Dalla Man C; Ma J; Cobelli C; Rizza RA; Vella A
    Metabolism; 2019 Apr; 93():10-17. PubMed ID: 30586575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The difference of glucostatic parameters according to the remission of diabetes after Roux-en-Y gastric bypass.
    Kim MK; Lee HC; Lee SH; Kwon HS; Baek KH; Kim EK; Lee KW; Song KH
    Diabetes Metab Res Rev; 2012 Jul; 28(5):439-46. PubMed ID: 22407971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immediate enhancement of first-phase insulin secretion and unchanged glucose effectiveness in patients with type 2 diabetes after Roux-en-Y gastric bypass.
    Martinussen C; Bojsen-Møller KN; Dirksen C; Jacobsen SH; Jørgensen NB; Kristiansen VB; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2015 Mar; 308(6):E535-44. PubMed ID: 25628424
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Roux-en-Y gastric bypass enhances insulin secretion in type 2 diabetes via FXR-mediated TRPA1 expression.
    Kong X; Tu Y; Li B; Zhang L; Feng L; Wang L; Zhang L; Zhou H; Hua X; Ma X
    Mol Metab; 2019 Nov; 29():1-11. PubMed ID: 31668381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alterations in gastrointestinal, endocrine, and metabolic processes after bariatric Roux-en-Y gastric bypass surgery.
    Anderwald CH; Tura A; Promintzer-Schifferl M; Prager G; Stadler M; Ludvik B; Esterbauer H; Bischof MG; Luger A; Pacini G; Krebs M
    Diabetes Care; 2012 Dec; 35(12):2580-7. PubMed ID: 22923664
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
    Carmody JS; Muñoz R; Yin H; Kaplan LM
    Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric bypass in the pig increases GIP levels and decreases active GLP-1 levels.
    Lindqvist A; Ekelund M; Pierzynowski S; Groop L; Hedenbro J; Wierup N
    Peptides; 2017 Apr; 90():78-82. PubMed ID: 28242256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones.
    Nannipieri M; Baldi S; Mari A; Colligiani D; Guarino D; Camastra S; Barsotti E; Berta R; Moriconi D; Bellini R; Anselmino M; Ferrannini E
    J Clin Endocrinol Metab; 2013 Nov; 98(11):4391-9. PubMed ID: 24057293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preserved Insulin Secretory Capacity and Weight Loss Are the Predominant Predictors of Glycemic Control in Patients With Type 2 Diabetes Randomized to Roux-en-Y Gastric Bypass.
    Nguyen KT; Billington CJ; Vella A; Wang Q; Ahmed L; Bantle JP; Bessler M; Connett JE; Inabnet WB; Thomas A; Ikramuddin S; Korner J
    Diabetes; 2015 Sep; 64(9):3104-10. PubMed ID: 25901097
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Marked improvement of insulin sensitivity without enhancement of GLP-1 and insulin secretion after Roux-en-Y gastric bypass surgery in a mildly obese patient with diabetes.
    Yamashita K; Sato Y; Oki K; Kishimoto H; Yamauchi K; Aizawa T
    Horm Metab Res; 2014 Jun; 46(6):424-6. PubMed ID: 24526371
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucagon-like peptide 1 (GLP-1) drives postprandial hyperinsulinemic hypoglycemia in pregnant women with a history of Roux-en-Y gastric bypass operation.
    Leutner M; Klimek P; Göbl C; Bozkurt L; Harreiter J; Husslein P; Eppel W; Baumgartner-Parzer S; Pacini G; Thurner S; Kautzky-Willer A
    Metabolism; 2019 Feb; 91():10-17. PubMed ID: 30448278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.